Long Read Sequencing Market Growth in the USA: Key Players, Trends, and Opportunities by 2028

The Long read sequencing, often referred to as third-generation sequencing, is transforming genomic research by providing longer DNA or RNA reads that improve analysis accuracy. Unlike short-read technologies, long read sequencing can generate reads exceeding 10 kilobases, enabling better identification of repetitive regions and structural variants. According to industry analysis, The Long Read Sequencing Market was valued at US$ 1,101.15 million in 2020 and is projected to reach US$ 5,334.68 million by 2028, expanding at a CAGR of 22.3 percent during 2021 to 2028. The Long Read Sequencing Market USA is experiencing remarkable growth, driven by rapid advancements in genomics and precision medicine. North America, particularly the United States, dominates the global landscape due to strong research infrastructure, government funding, and increasing adoption of advanced sequencing technologies. The US market alone is expected to grow at a significant pace, supported by the rising prevalence of chronic diseases and increasing demand for accurate genomic analysis.

The growing importance of long read sequencing in clinical diagnostics, cancer research, and personalized medicine is accelerating its adoption across healthcare and biotechnology sectors. Compared to traditional sequencing methods, long read sequencing enables better genome assembly, improved detection of structural variations, and enhanced accuracy in complex genomic regions.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006815

Market Overview and Growth Dynamics

The market growth is largely fueled by increasing applications in disease research, including cancer, rare genetic disorders, and infectious diseases. Additionally, advancements in sequencing platforms and declining sequencing costs are making these technologies more accessible to laboratories and research institutes.

In the United States, strong investments in genomics and precision medicine initiatives are creating a favorable ecosystem for market expansion. Government programs, academic collaborations, and private sector innovations are collectively driving the adoption of long read sequencing technologies.

Key Market Drivers

One of the major factors propelling the market is the growing demand for accurate and comprehensive genomic data. Long read sequencing addresses the limitations of short-read sequencing by enabling better detection of structural variations, allele phasing, and transcript isoforms.

Another key driver is the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. Since genetic factors play a crucial role in these conditions, the demand for advanced sequencing technologies is increasing rapidly.

Furthermore, technological advancements such as Single-Molecule Real-Time sequencing and nanopore sequencing are significantly improving sequencing efficiency and throughput. The SMRT technology segment held the largest market share in 2020, highlighting its widespread adoption.

Emerging Opportunities in the USA Market

The US long read sequencing market offers numerous growth opportunities for stakeholders. The increasing adoption of precision medicine is one of the most significant opportunities, as healthcare providers focus on personalized treatment strategies based on genetic profiles.

Another promising opportunity lies in cancer genomics. Long read sequencing enables detailed analysis of tumor genomes, helping in early detection, diagnosis, and treatment planning. Additionally, the growing use of sequencing in reproductive genomics and microbial research is further expanding the application scope.

The services segment is expected to witness the fastest growth during the forecast period, driven by increasing outsourcing of sequencing services by research organizations and healthcare institutions.

Moreover, the integration of artificial intelligence and bioinformatics tools with sequencing technologies is expected to enhance data analysis capabilities, opening new avenues for innovation and market growth.

Competitive Landscape and Key Players

The long read sequencing market is highly competitive, with several global and regional players focusing on innovation, partnerships, and product development to strengthen their market position. Key players operating in the market include:

·         Illumina Inc.

·         Oxford Nanopore Technologies

·         Pacific Biosciences of California Inc.

·         F. Hoffmann-La Roche Ltd

·         Revvity Inc. (PerkinElmer Inc.)

·         BaseClear B.V.

·         Bionano Genomics Inc.

·         Quantapore Inc.

·         Longas Technologies

·         TATAA Biocenter

These companies are investing heavily in research and development to introduce advanced sequencing platforms with higher accuracy and efficiency. Strategic collaborations, mergers, and acquisitions are also common strategies adopted by market players to expand their global footprint.

Market Segmentation Insights

The long read sequencing market is segmented based on technology, product, application, workflow, and end user. Among these, the sequencing workflow segment is expected to grow at a significant rate due to increasing demand for high-throughput sequencing solutions.

By end user, academic research institutes hold the largest share, driven by extensive genomic research activities and funding support. However, hospitals, clinics, and biotechnology companies are also emerging as key contributors to market growth.

Future Outlook

The future of the long read sequencing market in the United States looks highly promising, with continuous advancements in genomics and increasing adoption in clinical applications. The market is expected to witness significant growth driven by technological innovations, expanding research applications, and rising healthcare investments. As the demand for precision medicine continues to grow, long read sequencing will play a crucial role in shaping the future of healthcare. The integration of sequencing technologies with digital health platforms and data analytics tools will further enhance their impact across various medical and research domains.

Trending Reports:

·         Liquid Handling Systems Market Trends, Size & Forecast by 2034

·         Automated Liquid Handling System Market Key Companies and SWOT Analysis by 2031

·         Liquid Handling Technology Market Developments and Forecast by 2027  

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
Contact Person: Ankit Mathur 
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in: Korean|German|Japanese|French|Chinese|Italian|Spanish